Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide

Detalles Bibliográficos
Autores principales: Canella, Alessandro, Nieves, Hector Cordero, Sborov, Douglas W., Cascione, Luciano, Radomska, Hanna S., Smith, Emily, Stiff, Andrew, Consiglio, Jessica, Caserta, Enrico, Rizzotto, Lara, Zanesi, Nicola, Stefano, Volinia, Kaur, Balveen, Mo, Xiaokui, Byrd, John C., Efebera, Yvonne A., Hofmeister, Craig C., Pichiorri, Flavia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519243/
https://www.ncbi.nlm.nih.gov/pubmed/37747363
http://dx.doi.org/10.18632/oncotarget.28515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519243/
https://www.ncbi.nlm.nih.gov/pubmed/37747363
http://dx.doi.org/10.18632/oncotarget.28515

Ejemplares similares